Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/17/2010CN101884649A Traditional Chinese medicine for treating oculopathy
11/17/2010CN101884646A Medicinal composition for preventing and treating Alzheimer's disease and senility and preparation method thereof
11/17/2010CN101884644A Ointment for treating trauma
11/17/2010CN101884643A New purpose of pharmaceutical composition containing pioglitazone and heparin or low molecular heparin
11/17/2010CN101884642A Compound emulsifiable paste for treating acne and preparation method thereof
11/17/2010CN101884641A Method for building animal model for treating chronic renal injury by using traditional Chinese medicine
11/17/2010CN101884640A Application of oryzanol
11/17/2010CN101884639A Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
11/17/2010CN101884638A Application of 5alpha-androstane-3beta,5,6beta-triol in preparing neuro-protective medicaments
11/17/2010CN101884637A Medicinal composition for treating cardiovascular diseases and application thereof
11/17/2010CN101884636A Application of corosolic acid in preparation of antineoplastic medicine
11/17/2010CN101884635A Amino acid hypoglycemic capsule
11/17/2010CN101884634A Composition for treating cardiovascular diseases
11/17/2010CN101884633A Beta-lactam antibiotic solution and preparation method thereof
11/17/2010CN101884632A Compound preparation prepared from oseltamivir and ascorbic acid
11/17/2010CN101884631A Anti-tumor medicament based on alpha ketoglutaric acid and derivatives thereof
11/17/2010CN101884629A Controlled release preparation
11/17/2010CN101884628A Preparation method for fexofenadine hydrochloride-containing medicinal composition
11/17/2010CN101884627A Pioglitazone hydrochloride gastric residential sustained release tablet and preparation method thereof
11/17/2010CN101884626A Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
11/17/2010CN101884625A Berberine tannate dispersible tablet and preparation method thereof
11/17/2010CN101884624A Long-acting benserazide sustained release microsphere composition and preparation method thereof
11/17/2010CN101884623A Levodopa methyl ester slow-release microsphere composition and preparation method thereof
11/17/2010CN101884622A Benserazide sustained-release microspherical composition and preparation method thereof
11/17/2010CN101884621A Method for preparing salinomycin particle premix
11/17/2010CN101884619A Zolpidem tartrate controlled-release pellet and preparation method thereof
11/17/2010CN101884618A Long-circulating paclitaxel nanoparticles and preparation method thereof
11/17/2010CN101884617A Method for preparing proanthocyanidins liposomes
11/17/2010CN101884616A Docetaxel long-circulating liposome and preparation method thereof
11/17/2010CN101884615A Bulleyaconitine A liposome and preparation method thereof
11/17/2010CN101884614A Preparation of brain targeting chuanxiongzine oral oil package oil nano-emulsion
11/17/2010CN101884613A Moxifloxacinhydrochloride sodium chloride injection, preparation method thereof and use thereof
11/17/2010CN101884612A Preparation method of large volume ribavirin injection
11/17/2010CN101884611A Method for preparing medicinal invert sugar by sugar hydrolysis
11/17/2010CN101884412A Method for preparing natural compound calcium amino acid chelate
11/17/2010CN101536981B Clonidine hydrochloride multivesicular liposome and preparation method thereof
11/17/2010CN101492452B Sulfhydryl benzimidazole derivative containing dioxepane-pyridine
11/17/2010CN101440092B 2-indazole-4-aza indole-5-amino derivatives, and preparation and use thereof
11/17/2010CN101412719B Carbapenem derivatives
11/17/2010CN101411771B Chinese medicine preparation for treating bleeding symptoms and preparation method thereof
11/17/2010CN101398607B Printable audio format
11/17/2010CN101380329B Preparation method of arginine aspirin and powder and injection preparation thereof
11/17/2010CN101370497B Combination product with PARP inhibitors and cell toxin and its uses
11/17/2010CN101367811B Carbon substituted penems antibiotics
11/17/2010CN101367806B Formyl aniline substituted sulfhydryl pyrrolidine carbpenem compounds
11/17/2010CN101366854B Medicament for treating eczema
11/17/2010CN101362759B Dihydropyrrole methano substituted carbapenem derivates
11/17/2010CN101361740B Pharmacy use of 2,5- bis (hydroxymethyl)-3,6-dimethyl pyrazine and derivates thereof
11/17/2010CN101343282B Cephalosporin derivatives containing condensed nucleus
11/17/2010CN101337072B Preparation method of sustained and controlled release medicine material
11/17/2010CN101332198B Pharmaceutical use of 6-aryl-3-substituted carbonyl pyridine compound
11/17/2010CN101317844B Application of N-methyl-D-asparagic acid acceptor inhibitor in preparing contraceptive medicament
11/17/2010CN101305998B Use of aryl-3-substituted carbonyl pyridone compound
11/17/2010CN101301284B Uses of emodic acid or salt thereof for treating chronic nephritis or chronic renal failure
11/17/2010CN101297822B Ointment for curing mouth ulcer, children's aphthous ulcer and preparation method
11/17/2010CN101288648B Easy-to-administrate oxiracetam granular formulation and preparation method
11/17/2010CN101284109B Medicine for curing the burnt, scalded and frostbited corium to regenerate
11/17/2010CN101284007B Pharmaceutical use of aryl group substituted pyridone derivates in preparing medicine for tumour
11/17/2010CN101249079B Andrographolide succinic acid half-ester natrium potassium salt and preparations
11/17/2010CN101244059B Compound silibinin injection, preparation method and application thereof
11/17/2010CN101240006B Oleanane triterpene compound with C ring containing conjugated double bond and use thereof
11/17/2010CN101229126B Tinidazole compound nano silver microemulsion antibacterial medicine
11/17/2010CN101224205B Composition of atorvastatin and levorotatory amlodipine and preparing method thereof
11/17/2010CN101223139B 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
11/17/2010CN101214246B Palmatine nano particle preparations and preparation method thereof
11/17/2010CN101199632B Infusion medicament for treating nervous dermatitis
11/17/2010CN101199511B Andrographis lactone self-emulsification capsule of antibacterial antiphlogistic
11/17/2010CN101185677B Externally-applied medicine for treating zoster
11/17/2010CN101181321B Effective component of angelica as well as preparation method and application
11/17/2010CN101180052B Film coated preparation containing dextrose
11/17/2010CN101177413B 6-cyclohexyl methyl substituted S-DABO compound, method for synthesizing same and uses thereof
11/17/2010CN101168023B Plaster for treating protrusion of lumbar intervertebral disk
11/17/2010CN101167821B External-applied traditional Chinese medicine for curing breast cancer and its preparation method
11/17/2010CN101153024B Aryl substituted imidazoline-2-ketones derivant, producing method and uses of the same
11/17/2010CN101112371B Application of compound s2 in the preparation of anti-cancer medicine
11/17/2010CN101091705B Application of compounds in isorhodanic ester classes for treating diseases of prostate and skin cancer
11/17/2010CN101080231B Method for preparing galantamine hydrobromide
11/17/2010CN101080219B External patches containing etofenamate
11/17/2010CN101062027B Taurine and medical combination for treating cardiovascular and cerebrovascular diseases
11/17/2010CN101040937B Quality control method of Changyanning pills
11/17/2010CN101040883B Andrographis root extraction and its preparing process and application in preparing antithrombotic medicine
11/17/2010CN101011125B Method for processing instant color bean curd
11/17/2010CN101001623B Anticancer effect enhancer
11/16/2010US7834216 Chemical intermediates of and synthetic paths to active ingredient from Chinese herbal medicine plant Desmos dumosus, desmosdumotin C; fused ring derivatives
11/16/2010US7834194 Metabolic disorders; antidiabetic agents; hypoglycemic agents; obesity; hypotensive agents
11/16/2010US7834188 Insecticidal N-substituted sulfoximines
11/16/2010US7834182 histamine H3 receptor antagonists; metabolic disorders, sleep disorders, cardiovascular disorders, alcoholism, drug addiction, memory disorders, Alzheimer's, Parkinson's disease; 2-(4-piperidinylpiperidinyl)pyrimidine compounds such as 2-[(4-piperidin-1-yl)piperidin-1-yl]-5-(3-pyridyl)pyrimidine
11/16/2010US7834181 Small-molecule Hsp90 inhibitors
11/16/2010US7834179 6',7',8',9'-tetrahydro spiro[3H-indole-3,7'-(2H-pyrido[2,1-c][1,2,4]triazine)]-2,3'(1H)-dione compounds; small molecule inhibitors of the MDM2-p53 interaction
11/16/2010US7834178 Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
11/16/2010US7834174 Per-6-guanidino-, alkylamino-cyclodextrins, methods of their synthesis and their use for the compaction of DNA and intercellular delivery
11/16/2010US7834172 comprising an oligonucleotide and cetalkonium chloride (CKC) also called Benzyl n-hexadecyl dimethylammonium chloride wherein the ratio of CKC to mers of the oligonucleotide is below 0.55; prevention, treatment or relief of eye, lung, and/or respiratory tract conditions
11/16/2010US7834063 4-[(Cyclopropylmethyl)(2-{[4-(1,1-dimethylethyl)phenyl]oxy}ethyl)amino]-2-(trifluoromethyl)benzonitrile; modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors; osteoporosis, muscle wasting,endometriosis, cardiovascular disease; breast, uterine cancer, prostatic hyperplasia
11/16/2010US7834062 Aminoalkylphenols, methods of using and making the same
11/16/2010US7834061 Process for producing 1,4-dihydroxy-2-naphthoic acid
11/16/2010US7834060 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
11/16/2010US7834059 for topical ophthalmic administration; nepafenac, a carbomer, a nonionic surfactant, a tonicity-adjusting agent, a pH-adjusting agent, purified water, and optionally a preservative and a chelating agent
11/16/2010US7834058 Administering orally/parentally octadecatrien-9,11,13-oic acid;normalize/improve impaired glucose tolerance and type 2 diabetes; preventand treat hyperglycemia and hyperinsulinemia; to attenuate the detrimental effects of high fat diets; minimize abdominal fat accumulation
11/16/2010US7834057 applying first composition containing glycolic acid, second containing Ascorbylmethylsilanol Pectinate, and third including Retinyl Palmitate Polypeptide, Ascorbylmethylsilanol Pectinate, Tocopheryl Polypeptide, Cholecalciferol Polypeptide, and Niacinamide Polypeptide
11/16/2010US7834056 Pharmaceutical composition for gout
1 ... 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 ... 7860